Reuters logo
4 个月前
BRIEF-Jazz Pharma says gave Roxane non-exclusive license under Xyrem patents to produce generic sodium oxybate product
2017年4月5日 / 晚上9点54分 / 4 个月前

BRIEF-Jazz Pharma says gave Roxane non-exclusive license under Xyrem patents to produce generic sodium oxybate product

1 分钟阅读

April 5 (Reuters) - Jazz Pharmaceuticals Plc

* Jazz Pharma - also gave Roxane non-exclusive license under Xyrem patents to make, market its generic sodium oxybate product under Roxane ANDA in Territory Source text: (bit.ly/2p2w878) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below